Objective: To investigate the association between a single nucleotide polymorphism rs2274223 (adenine [A] to guanine [G]) in the phospholipase C epsilon 1 (PLCE1) gene and susceptibility to colorectal cancer (CRC). Methods: The PLCE1 rs2274223 polymorphism was genotyped in patients with CRC and age-and sex-matched cancer-free control subjects from a Chinese population in a case-control study. PLCE1 mRNA levels in pair-matched tumour and adjacent noncancerous tissue were evaluated by real-time quantitative reverse transcription-polymerase chain reaction. Results: A total of 417 patients with CRC and 416 control subjects were enrolled in the study. The AG and GG genotypes of PLCE1 rs2274223 were associated with a significantly increased risk of CRC (for AG þ GG versus AA: adjusted odds ratio 1.52, 95% confidence interval 1.15, 2.00). PLCE1 mRNA levels were significantly lower in tumours than in adjacent noncancerous tissue. Lower levels of PLCE1 mRNA were observed in both AG and GG genotype carriers compared with the AA genotype carriers. Conclusions: These results indicate that the PLCE1 rs2274223 A > G change might reduce gene expression and that the variant G genotype might contribute to the increased risk of CRC.
Introduction
Colorectal cancer (CRC) is one of the most aggressive cancers and causes approximately 1 million deaths worldwide each year. 1 It is a frequent cause of cancer-related death in developed countries. 1 With improvements in the standard of living and changes in lifestyle, food and the environment, the incidence of CRC is constantly increasing in China, where it is now the third most frequent malignancy. 2 Although advances in surgical techniques, improved chemotherapy and early detection have decreased the mortality rate of CRC, 1 there is still an urgent need for early diagnosis and effective cancer prevention because of the poor prognosis and lack of novel treatments for this disease.
A number of theories have been put forward to explain the aetiology of CRC, such as the classical adenoma-carcinoma sequence model. 3 Both environmental and genetic factors appear to contribute to the tumorigenesis of CRC. 3 Environmental risk factors (such as an unbalanced diet, nutritional deficiencies, environmental exposure to carcinogens, and infectious agents such as viruses and bacteria) may also contribute to the carcinogenesis of CRC. [4] [5] [6] [7] [8] Genetic polymorphisms in a variety of genes have been shown to be involved in the susceptibility to CRC, particularly for those genes involved in cell-cycle control, 9 DNA repair, 10 metabolism, 11 insulin resistance, obesity and glucose level regulation, 12 and inflammation. 13 Phospholipase C epsilon 1 (PLCE1), encoded by the PLCE1 gene on chromosome 10q23, belongs to the phospholipase family of enzymes and catalyses the hydrolysis of polyphosphoinositides to generate the secondary messengers inositol 1,4,5-triphosphate and diacylglycerol, thereby contributing to intracellular signalling. [14] [15] [16] PLCE1 protein initiates a cascade of intracellular responses that result in cell growth, differentiation and gene expression. 14, 16, 17 PLCE1 has been reported to play a critical role in carcinogenesis and progression of a variety of human cancers including those of the oesophagus, 18 stomach, 19 skin, 20 bladder, 21 and head and neck. 22 Two large-scale genome-wide association studies simultaneously showed that a new and notable lowpenetrance susceptibility single nucleotide polymorphism (SNP) rs2274223, located in exon 26 of the PLCE1 gene, was strongly associated with increased risk of oesophageal squamous cell carcinoma and gastric cancer in Chinese populations. 23, 24 Subsequent research confirmed that the SNP rs2274223 was a critical risk factor for the incidence of oesophageal squamous cell carcinoma and gastric cancer. 19, [25] [26] [27] There is also evidence that the PLCE1 SNP rs2274223 adenine (A) >guanine (G) change might reduce gene expression, and that variant G genotypes might contribute to the increased risk of oesophageal squamous cell carcinoma. 18 PLCE1 mRNA levels were also shown to be significantly lower in gastric tumours compared with adjacent normal tissue, which might be associated with the SNP rs2274223. 19 Research has demonstrated that PLCE1 gene expression was downregulated in sporadic CRC and that this gene exhibited a suppressive role on the incidence of CRC. 28, 29 However, no association between the potentially functional variants of the PLCE1 gene and susceptibility to CRC has been reported.
The aim of the present study was to evaluate the possible correlation between the SNP rs2274223 in the PLCE1 gene and susceptibility to CRC in a Chinese population. The PLCE1 mRNA levels in pairmatched tissue samples were analysed and the results stratified according to different rs2274223 genotypes.
Patients and methods

Study population
This hospital-based case-control study enrolled consecutive Han Chinese patients with newly diagnosed and histopathologically confirmed CRC, receiving care at the Department of Anus, Rectum and Colon Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China between May 2007 and May 2012.
In addition, 416 Han Chinese subjects from Zhejiang Province, who were healthy according to a physical examination, were recruited from several clinics at the First Affiliated Hospital, Zhejiang University School of Medicine between May 2007 and May 2012 with the selection criteria including no history of cancer. These cancer-free control subjects were matched to the patients based on age (AE5 years) and sex. At recruitment, each study participant was interviewed to gather demographic data (such as age and sex) and environmental exposure history, including smoking status ( ' no' for smoking included nonsmokers and former smokers) and alcohol consumption ('no' for alcohol consumption included former alcohol drinker and those who had never drunk alcohol). Tumours were graded according to the WHO Classification of Tumours of the Digestive System.
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This case-control study was approved by the Ethics Committee of the First Affiliated Hospital, College of Medicine, Zhejiang University (no. 20120118-01). Written informed consent was provided by all of the study participants.
Genotyping
Blood samples (about 3 ml) were collected from the antecubital veins of CRC patients or healthy donors after an overnight fast during the first examination. Genomic DNA was extracted immediately from 200 ml of ethylenediaminetetra-acetic acid (20 
Quantitative real-time RT-PCR
Noncancerous colorectal tissue was collected from an area of mucosa 15 cm away from the tumour when the tumour samples were collected. Tissue samples were divided into two parts: one was for histopathological examination and the other was transferred into a cryotube and immediately frozen in liquid nitrogen before further analysis. Total RNA was isolated from 50 mg of tumour tissue and pair-matched noncancerous tissue adjacent to the tumour using the RNeasy Õ Mini kit (QIAGEN) according to the manufacturer's instructions. The quality and quantity of the RNA were assessed using a NanoDrop TM 1000 instrument (Thermo Fisher Scientific, Wilmington, DE, USA). A total of 36 CRC tumour samples and their corresponding noncancerous tissues were selected to quantify PLCE1 mRNA levels. These samples were selected at random from the total samples (12 with AA, 12 with AG, 12 with GG): we only identified the genotypes of blood samples whose genotypes we considered as the same as the genotypes in tumour or healthy tissues.
Quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) was used to measure the amount of PLCE1 mRNA in pair-matched tissue samples from patients with different PLCE1 genotypes. For each sample, 1 mg of total RNA was subjected to reverse transcription using the PrimeScript TM RT Master Mix System (TaKaRa, Dalian, China). A SYBR Õ Green real-time PCR method was used to assess the PLCE1 mRNA levels in colon tissue. Primer sequences for RT-PCR for the PLCE1 gene were 5 0 -CCTGGG CATAAGCACTACCAAG-3 0 (forward) and 5
0 -GTCTTGAGGATCAGAACCACT CC-3 0 (reverse). 19 Primer sequences for the glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH) were 5 0 -GCACCGTCAA GGCTGAGAAC-3 0 (forward) and 5 0 -ATG GTGGTGAAGACGCCAGT-3 0 (reverse). All the primers were obtained from Invitrogen (Shanghai, China). Real-time PCR was performed in a Bio-Rad CFX96 Touch TM Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA) using 1 ml of the resulting cDNA from the RT step, 10 ml of SYBR Õ Green PCR Master Mix (TaKaRa) and 4 pmol each of the forward and reverse primers. The cycling programme involved preliminary denaturation at 95 C for 30 s, followed by 40 cycles of denaturation at 95 C for 15 s and annealing at 60 C for 30 s; amplification fluorescence was monitored at 60 C at the end of each cycle. Three replicates were performed for each sample and the quantitative real-time PCR products were analysed using Bio-Rad CFX Manager TM software, version 3.0 (Bio-Rad) using the 2 ÀÁÁCT method. 31 
Statistical analyses
All statistical analyses were performed using the SPSS Õ software package, version 16.0 (SPSS Inc., Chicago, IL, USA) for Windows Õ . The Hardy-Weinberg equilibrium was tested by a goodness-of-fit 2 -test to compare the observed genotype frequencies compared with the expected frequencies among the control subjects. Differences in the distributions of demographic characteristics, selected variables, and the genotypes of the PLCE1 rs2274223 SNP between patients with CRC and control subjects were evaluated using a 2 -test-based Q-test and the Wilcoxon signed-rank test. Stratification analysis was performed to evaluate the potential association of genetic variants of the PLCE1 rs2274223 polymorphism with risk in subgroups based on clinical characteristics. The associations between the PLCE1 variants and CRC risk were estimated by calculating the odds ratios (OR) and 95% confidence intervals (CI), using both univariate and multivariate logistic regression analysis with adjustment for age, sex, smoking status and alcohol consumption status. Paired-sample Student's ttest was used for the comparison of mRNA levels between pair-matched tissue samples from patients with different PLCE1 genotypes. Two-sided tests were used for statistical analysis and a P-value < 0.05 was considered statistically significant. The statistical power was calculated using Power Table 2 . The observed genotype frequencies for the PLCE1 gene rs2274223 polymorphism agreed with that expected according to the Hardy-Weinberg equilibrium in the control subjects. The genotype distribution between the patients with CRC and the control subjects was significantly different for rs2274223 (P ¼ 0.0118; 2 -test of the difference between the three genotype groups). After adjustment for age, sex, smoking and alcohol drinking status, a significantly increased risk of CRC was associated with the variant genotypes AG þ GG of rs2274223 with an adjusted OR of 1.517 (95% CI 1.148, 2.004) compared with the AA genotypes.
Stratification analysis was performed to evaluate the potential association of genetic variants of the PLCE1 rs2274223 polymorphism with risk in subgroups based on clinical characteristics. As shown in Table 3 , the stratification analysis indicated that the risk associated with the rs2274223 variant AG þ GG genotypes was more evident in younger patients ( 65 years; adjusted OR 2.287, 95% CI 1.553, 3.368), men (adjusted OR 1.680, 95% CI 1.145, 2.467), and those that did not drink alcohol (adjusted OR 1.538, 95% CI 1.113, 2.125) compared with those patients without any variant genotypes (AA).
The association between the PLCE1 rs2274223 polymorphism and the clinical characteristics of CRC was also examined ( To investigate the potential association between PLCE1 SNP rs2274223 variants and PLCE1 mRNA levels, samples of A, adenine; G, guanine; OR, odds ratio; CI, confidence interval; NS, no statistically significant difference (P ! 0.05). Obtained in logistic regression models with adjustment for age, sex, smoking and alcohol drinking status. b P-value for heterogeneity test using tumour and pair-matched noncancerous tissues adjacent to the tumour from patients with different PLCE1 genotypes were used to determine PLCE1 mRNA levels using RT-PCR (Figure 1) . A total of 36 CRC tumour samples and their corresponding noncancerous tissues were selected at random to quantify PLCE1 mRNA levels. PLCE1 mRNA levels were significantly lower in the CRC tumours than in the adjacent noncancerous tissues (n ¼ 36; twosided Student's t-test; P < 0.001). Lower PLCE1 mRNA levels were observed in both AG and GG genotype carriers than in those patients that were AA genotype carriers (P ¼ 0.0364 for AG versus AA and P ¼ 0.0146 for GG versus AA, respectively; two-sided Student's t-test).
Discussion
This hospital-based case-control study investigated the association between a potentially functional SNP rs2274223 in the PLCE1 gene with the risk of CRC in a Han Chinese population. The current results showed that the SNP rs2274223 polymorphic genotype AG þ GG of the PLCE1 gene (combined genotypes) might contribute to the risk of CRC, and this risk was more evident in younger patients ( 65 years), men and those who did not drink alcohol. To the best of our knowledge, this is the first report on the relationship between the SNP rs2274223 polymorphic genotype AG þ GG of the PLCE1 gene and the risk of CRC.
Our study also demonstrated a role of the PLCE1 gene and its potential functional variant rs2274223 in the aetiology of CRC at the mRNA level in pair-matched tissue samples from patients with different PLCE1 genotypes. The PLCE1 gene is a member of the phospholipase C family. [14] [15] [16] Structural analysis revealed that the PLCE1 protein contains one cell division cycle 25 domain at the N-terminus and two Ras-associating domains at the C-terminus, which are all associated with Harvey-Ras and Ras-related protein 1 A activity. 14, 16 Therefore, PLCE1 acts as an effector of the Ras family small guanine triphosphatases and plays a critical role in regulating cell growth, differentiation and development. 14, 16, 17 Other studies have found that some mutations in the PLCE1 gene lead to early onset nephritic syndrome and isolated diffuse mesangial sclerosis in humans, 33, 34 but this gene might also be linked to carcinogenesis. 16 Research has also revealed that the PLCE1 gene was downregulated in tumour tissue from patients with CRC and that it might play a crucial Figure 1 . Phospholipase C epsilon 1 (PLCE1) gene expression levels, measured using reverse transcription-polymerase chain reaction, are presented as the PLCE1 mRNA levels in colorectal cancer (CRC) tissue matched tissue adjacent to the tumour. Data points represent fold differences between each pair-matched sample set. Horizontal bars represent the calculated medians of the overall group and each subgroup. Levels of PLCE1 mRNA were downregulated in CRC tissues compared with pair-matched normal tissues. 'Total' includes the data from patients (n ¼ 36) with different PLCE1 genotypes and the three subgroups show the samples stratified by the three different PLCE1 rs2274223 genotypes (n ¼ 12 per group). The levels of PLCE1 mRNA were determined relative to the internal control glyceraldehyde-3-phosphate dehydrogenase (GAPDH). A, adenine; G, guanine. *P < 0.05, two-sided Student's t-test.
role in CRC formation. 28, 29 To date, there have been no reports of studies that have investigated the association between genetic variations of the PLCE1 gene and susceptibility to CRC.
In the present study, the PLCE1 rs2274223A >G SNP was demonstrated to be associated with the risk of CRC. This SNP causes an amino acid change from histidine to arginine in the calcium-dependent lipidbinding C2 domain of the PLCE1 protein. 18 The rs2274223 SNP in the PLCE1 gene was first identified as a risk factor for oesophageal squamous cell carcinoma and gastric cancer in Chinese populations in two independent genome-wide association studies. 23, 24 These results were reproduced by others. 18, 19, 25, 35 Although Chinese patients formed the majority of the study populations in these studies, 18, 19, 35 the association between the PLCE1 rs2274223 SNP and the risk for cancer has also been demonstrated in Caucasian populations. 25, 26 These results and the findings of the current study suggest that the rs2274223 SNP of the PLCE1 gene might be a crucial risk factor for tumours of the digestive system (including CRC), and that it could be used as a biomarker for the diagnosis of these cancers. Individuals carrying PLCE1 rs2274223 AG þ GG genotypes had higher survival rates than those carrying the AA genotype, suggesting that the rs2274223 G allele might be associated with prognosis in patients with gastric cancer. 27 However, in this current study, survival information for the patients with CRC was not included. Further studies focusing on the association between the rs2274223 SNP of the PLCE1 gene with prognosis of patients with CRC are needed.
In the stratification analysis undertaken in this current study, the rs2274223 SNP of the PLCE1 gene was more evident in younger patients ( 65 years), in men and in those who did not drink alcohol. These current findings were consistent with the concept that individuals with high-risk genetic susceptibility are more likely to develop cancer when they are exposed to a low level of alcohol exposure. 19 For alcohol drinkers, the effect of genetic variations may be overwhelmed by the strong impact of environmental carcinogens. In contrast, for those who have been exposed to a low level of alcohol, genetic variations may play a dominant role in the initiation of carcinogenesis. Cancer is a complex and multifactorial disease: gene-gene and geneenvironment interactions may occur, and a single genetic variant is usually insufficient to predict the overall risk. Further research is required to elucidate the role of other functional SNPs in the PLCE1 gene and to investigate the impact of other related genes involved in similar biological pathways that might be involved in the aetiology of CRC.
To test the hypothesis that the rs2274223 SNP of the PLCE1 gene might play a functional role in the aetiology of CRC through altering the PLCE1 gene expression level, the mRNA levels from paired samples of CRC tumours and adjacent noncancerous tissue were measured using real-time RT-PCR. Overall, the current results showed that the PLCE1 mRNA level was much lower in the tumours than in adjacent noncancerous tissue samples, which was consistent with the results from two other studies of CRC. 28, 29 Such findings were also observed in Chinese patients with oesophageal squamous cell carcinoma or gastric adenocarcinoma. 18, 19 These results suggest that the PLCE1 gene might play a suppressive role in the carcinogenesis of a variety of cancers including CRC. Although this current study demonstrated that the G allele was related to lower PLCE1 mRNA levels, studies with larger population sizes are needed to validate this finding. Higher PLCE1 protein levels have been demonstrated in oesophageal squamous cell carcinoma tumour tissue compared with matched normal tissue. 24 Although protein levels generally parallel the mRNA level,
